Creating outside partnerships for community oncology practices is important because these partnerships move the industry towards value-based payment models, said Kim Woofter, executive vice president of strategic alliances and practice innovation at the Advanced Centers for Cancer Care.
Creating outside partnerships for community oncology practices is important because these partnerships move the industry towards value-based payment models, said Kim Woofter, executive vice president of strategic alliances and practice innovation at the Advanced Centers for Cancer Care.
Transcript (slightly modified)
What is the importance of setting up outside partnerships for a community oncology practice to be successful?
I think oncology practices today really need to set up partnerships with data analytics firms, which is a little bit different than it was years ago. Years ago, you set up partnerships with hospitals, or other practices, or neighboring primary care. Data analytics now gives you the tool to work with a new set of partners—basically the employer. I think that’s what we see in our market the most is the data analytics we have in relation to cost-of-care, site-of-service, and how better-to-do care management has led employers to do some direct contracting, to do some channeling of their employees, and then has helped to encompass the team a little bit differently.
So, it’s different now than it was 5 and 10 years ago, and our focus most recently has been on data analytics, so you better understand your population and your business model and then to partner that with employers.
How do these partnerships help as the industry moves more toward value-based payment models?
They’re helping because we’re doing a lot of care management. In your value-based care model you have to have true control over the whole continuum of care for the patient. So, that’s everything from toxicity management to end-of-life management. If you’re truly going to get value, you have to have control of that sector and that data analytics helps you to do that.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More